Skip to content

NSI-189

Also called Neurogenic antidepressant

Stimulates hippocampal neurogenesis and increases hippocampal volume.

  • TypeSmall molecule
  • FormOral
  • Researched forCognitive & Mood

Where to get NSI-189

Disguised Alpha
Oral
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop oral at Disguised Alpha

The short version

  • Why people research itFocus, memory, neuroprotection, mood and stress resilience.
  • What the evidence isReached phase 2 in humans for major depressive disorder, run by Neuralstem.
  • What to watchMood that worsens, or any thoughts of self-harm.

How NSI-189 works

Stimulates hippocampal neurogenesis and increases hippocampal volume; studied for depression and cognitive recovery.

NSI-189 is a small molecule with a published structure and no published target. The compound is NSI-189 phosphate, (4-benzylpiperazin-1-yl)-[2-(3-methyl-butylamino)pyridin-3-yl]methanone Liu 2019 — a benzylpiperazine joined by a ketone to an aminopyridine.

That is not an oversight. It is how the compound was found. It came out of a phenotypic screen for proliferation of human hippocampus-derived neural stem cells Liu 2019 — a screen that asks ‘does this make more cells?’ rather than ‘does this bind that?’.

  • Oral

On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)

Research on NSI-1895 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • Reached phase 2 in humans for major depressive disorder, run by Neuralstem. The trial missed its primary endpoint on the MADRS depression scale.

  • What did move is the part usually left out: secondary cognitive measures improved significantly, and patient-reported outcomes favored the drug. A later analysis argued the trial was underpowered for the effect size seen. That is a different situation from a compound that did nothing.

Correlative data

  • Community use for mood and cognition. Reported experience is of a slow onset over weeks, consistent with a neurogenesis mechanism rather than a monoamine one.

How the mechanism reads

  • A nicotinamide derivative that stimulates neurogenesis in the hippocampus — it increased hippocampal volume in rodent work, which is notable because hippocampal atrophy is a well-replicated finding in depression.

    Experimental, animal or cell
  • Acting on neurogenesis rather than on serotonin is why the timescale is weeks and why the cognitive signal in the trial may be the more meaningful result.

    Mechanistic

Sources

  • Fava M, et al. Molecular Psychiatry 2016 · PMID 26643541
  • Papakostas GI, et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Molecular Psychiatry 2020 · PMID 30626911
  • Johe KK, et al. NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry 2020 · PMID 32722729
  • Jolivalt CG, et al. Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes 2019 · PMID 31492662
  • Jolivalt CG, et al. Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes. Journal of Diabetes Research 2022 · PMID 35967127
  • Liu Y, et al. Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189. Neuropharmacology 2019 · PMID 30408487

NSI-189 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Age under 25 or any suicidal thoughts: neuroactive antidepressant-class compounds can raise risk early.
  • Bipolar disorder: an antidepressant-type effect can switch mood toward mania.
  • SSRIs, MAOIs or other serotonergic drugs: interaction data are missing.
  • Pregnancy: promoting hippocampal neurogenesis has no fetal safety data.
  • Seizure history: the phase 2 trials excluded it.

What’s expected

  • Possible slow mood and thinking benefit over weeks, if the neurogenesis mechanism holds.
  • Headache or fatigue, common early with neuroactive small molecules.
  • Light nausea or sleep changes.

Watch for

  • Mood that worsens, or any thoughts of self-harm.
  • Several days of unusually high energy with little sleep.
  • A seizure.
  • Intense restlessness.

Labs that tell you it’s working

  • TSH (Thyroid-Stimulating Hormone)
  • Vitamin D (25-Hydroxy)
  • Vitamin B12 & Folate
  • Comprehensive Metabolic Panel (CMP)

NSI-189 stimulates hippocampal neurogenesis; its phase 2 results were mixed, and mood-relevant labs rule out other causes of low mood. PMID 30626911 PMID 26643541

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

NSI-189 FAQ4 common questions

Is NSI-189 approved for human use?
No. NSI-189 is a research compound.
What is NSI-189 researched for?
Focus, memory, neuroprotection, mood and stress resilience.
Which labs show whether it's doing anything?
TSH; Vitamin D; Vitamin B12 & Folate; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for NSI-189: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what NSI-189 is. Skool covers how it is run.

Free on this page

What NSI-189 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What NSI-189 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool